High Cholesterol in Young Adults: Prevention, Testing and When to See a Doctor
High cholesterol is often treated as a problem for middle age. In reality, the arteries keep a running tally from childhood: the longer LDL cholesterol stays elevated, the more plaque builds up. Young, fit people, including athletes, are not exempt, and some habits common in gym culture can push lipid levels in the wrong direction. Here is what young adults should know about cholesterol and when a doctor's visit is warranted.
Why cholesterol matters early
LDL cholesterol is carried in particles that can penetrate the artery wall and start the process of atherosclerosis. A consensus statement from the European Atherosclerosis Society led by Ference and colleagues concluded, based on genetic, epidemiologic and clinical trial evidence, that LDL causes atherosclerotic cardiovascular disease and that risk depends on both the level and the duration of exposure.
This "cumulative exposure" idea explains why young adults should care. Someone whose LDL is moderately elevated from age 20 accumulates far more lifetime exposure than someone whose level rises only at 50. Plaques that cause heart attacks in a person's 40s or 50s often began forming decades earlier.
US guidelines from the American College of Cardiology and American Heart Association, authored by Grundy and colleagues, emphasize lifestyle in young adults and recommend considering drug therapy when LDL is very high or when other risk factors are present.
Being lean and active lowers cardiovascular risk overall, but it does not cancel out a genetic tendency to high LDL, and some athletes have lipid profiles far worse than their fitness would suggest.
Common causes in young people
The most important cause to recognize is familial hypercholesterolemia (FH), an inherited disorder that impairs LDL clearance. It affects roughly one in 250 people. Untreated, it markedly increases the risk of early heart attacks. Nordestgaard and colleagues emphasized that FH is greatly underdiagnosed, and that most people who carry it do not know.
Other contributors include diet high in saturated fat, excess weight, insulin resistance, hypothyroidism, kidney disease and certain medications such as isotretinoin and some antipsychotics. Very low-carbohydrate, high-saturated-fat diets can raise LDL dramatically in some people.
Anabolic-androgenic steroids deserve particular attention in athletic populations. Hartgens and colleagues found that steroid use lowered HDL cholesterol and its key protein apolipoprotein A1, with oral steroids producing the largest unfavorable changes. Lowered HDL and raised LDL together create a more atherogenic profile, and these changes have been associated with accelerated coronary disease in long-term users.
Lipoprotein(a), or Lp(a), is a separate, genetically determined particle that raises cardiovascular risk independently of LDL. Its level is set largely at birth and changes little with lifestyle. A European Atherosclerosis Society statement by Kronenberg and colleagues recommended measuring it at least once in every adult's lifetime.
| Cause | Clues | Key action |
|---|---|---|
| Familial hypercholesterolemia | LDL ≥190 mg/dL, family history of early heart disease | Specialist evaluation, family screening |
| Diet and weight | High saturated fat intake, rising waistline | Dietary changes, recheck in 3 months |
| Hypothyroidism | Fatigue, weight gain, high TSH | Thyroid testing and treatment |
| Anabolic steroids | Very low HDL, raised LDL | Stop use, medical follow-up |
| High Lp(a) | Family history despite normal LDL | One-time measurement |
Testing: when and what to ask for
The National Heart, Lung, and Blood Institute expert panel recommended universal cholesterol screening for children once between ages 9 and 11 and again between 17 and 21. ACC/AHA guidance supports assessing risk factors, including lipids, in adults starting at age 20 and periodically thereafter.
A standard lipid panel measures total cholesterol, LDL, HDL and triglycerides. Fasting is no longer required for most people, although it may be requested if triglycerides are high. US labs report results in milligrams per deciliter (mg/dL).
Useful additions in certain cases include:
- apolipoprotein B (apoB), which counts atherogenic particles and is useful when triglycerides are high;
- Lp(a), measured once;
- TSH, glucose or HbA1c, liver and kidney function to look for secondary causes;
- a coronary artery calcium scan in selected adults when the decision about treatment is uncertain, though it is less informative in younger people.
Athletes who use or have used anabolic steroids should tell their doctor, since this changes interpretation and follow-up. Physicians are bound by confidentiality, and honest disclosure is essential for appropriate care.
Prevention through lifestyle
For most young adults with mildly elevated cholesterol, lifestyle changes are the first step. Replacing saturated fats from fatty meats, butter and coconut oil with unsaturated fats from olive oil, nuts and fish lowers LDL. Increasing soluble fiber from oats, beans and psyllium has a modest additional effect.
Regular aerobic exercise raises HDL and lowers triglycerides, and resistance training contributes to better metabolic health. Maintaining a healthy weight, limiting alcohol and not smoking or vaping further reduce cardiovascular risk.
Some supplements have modest evidence: plant sterols and stanols, psyllium and possibly soy protein lower LDL by a few percent. Red yeast rice contains a natural statin compound and should be treated as a drug, not a harmless supplement. Products that claim to "detox" arteries lack evidence.
Athletes should avoid anabolic steroids and be cautious with high-saturated-fat "bulking" diets. Monitoring lipids before and after major dietary changes helps identify individuals who respond strongly.
When to see a doctor and treatment options
You should talk to a doctor if you have any of the following:
- LDL of 190 mg/dL or higher, which suggests possible familial hypercholesterolemia;
- a parent or sibling with a heart attack or stroke before age 55 in men or 65 in women;
- physical signs such as yellowish deposits on the eyelids or tendons, or a gray ring around the cornea at a young age;
- persistently elevated LDL despite lifestyle changes, especially with diabetes, high blood pressure or smoking;
- past or current use of anabolic steroids.
For people with very high LDL or FH, US guidelines recommend statin therapy, often starting in young adulthood or even childhood in confirmed FH. Other options include ezetimibe and PCSK9 inhibitors. These medications are well studied, and decisions should weigh lifetime risk rather than short-term risk alone.
Diagnosing FH has implications for relatives. "Cascade screening" of parents, siblings and children can identify others who would benefit from early treatment.
Conclusions of the Editorial Team
High cholesterol in young adults matters because arterial damage depends on how long LDL stays elevated. Lean, active people can still have dangerous levels, particularly with familial hypercholesterolemia, high Lp(a) or anabolic steroid use.
A lipid panel in your early twenties, a one-time Lp(a) test and honest discussion with a doctor about family history and substance use allow early, effective prevention.
If you want to learn more, see our articles on what HDL really tells you, psyllium and other fibers for cholesterol and the cardiovascular effects of anabolic steroids.
References
- Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol. Circulation. 2019;139(25):e1082–e1143.
- Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. Eur Heart J. 2017;38(32):2459–2472.
- Nordestgaard BG, Chapman MJ, Humphries SE, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease. Eur Heart J. 2013;34(45):3478–3490.
- Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents. Summary report. Pediatrics. 2011;128(Suppl 5):S213–S256.
- Hartgens F, Rietjens G, Keizer HA, Kuipers H, Wolffenbuttel BH. Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a). Br J Sports Med. 2004;38(3):253–259.
- Kronenberg F, Mora S, Stroes ESG, et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J. 2022;43(39):3925–3946.
